15 Jan 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Seegene, a leading developer of multiplex molecular technologies and multiplex molecular diagnostic tests, announced the appointment of Dr John G Hurrell as its senior executive vice president.
In this position, Dr Hurrell will run Seegene's B2B business unit, which is responsible for global licensing, original equipment manufacturing (OEM) and companion diagnostic deals with global top-tier healthcare players. The unit is also responsible for widening customer base within the clinical laboratory test market.
"We are excited to have Dr Hurrell join Seegene's leadership team," said Dr Jong-Yoon Chun, founder, CTO and CEO of Seegene. "John's distinguished track record of growing companies in the healthcare industry will be an asset as we continue to drive Seegene's growth both organically and through strategic acquisitions."
Most recently, Dr Hurrell was the president and general manager of Focus Diagnostics, a subsidiary of Quest Diagnostics. At Focus, Dr Hurrell led the development and launch of more than 70 molecular tests and successfully gained 510(k) approvals for six products.
Prior to that Dr Hurrell served as VP of business development at Quest Diagnostics. He also held numerous management positions at several healthcare firms, including senior VP and general manager positions at TriPath Oncology, a subsidiary of TriPath Imaging, which was acquired by Becton, Dickinson and Company.